Facile Synthesis of CoNi Bimetallic Nanoparticle Decorated Reduced Graphene Oxide as Efficient and Low-Cost Counter Electrode for Dye-Sensitized Solar Cells

Wei, Liguo; Chen, Wei; Jia, Chenyang; Wang, Dong; Li, Ming; Dong, Yongli; Song, Weina; Liu, Lilai; Yang, Yang

doi:10.1166/jnn.2019.16862

Cited by 3 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The hydrothermal method is generally applicable to reactions with lower reduction potentials that are not easily reduced directly. Up to date, some BMNs synthesized from metal precursors with lower reduction potentials have been prepared with this method, such as CuNi [29,30], Ni-Fe [31], CoNi [32], and NiRe [33]. For example, Gai et al designed and prepared NiFe alloy NPs only using hydrochar, Ni(II) nitrate nonahydrate, and Fe(III) nitrate nonahydrate, as shown in Figure 1b.…”

Section: Hydrothermal Methodsmentioning

confidence: 99%

Bimetallic Nanomaterials: A Promising Nanoplatform for Multimodal Cancer Therapy

et al. 2022

View full text Add to dashboard Cite

Bimetallic nanomaterials (BMNs) composed of two different metal elements have certain mixing patterns and geometric structures, and they often have superior properties than monometallic nanomaterials. Bimetallic-based nanomaterials have been widely investigated and extensively used in many biomedical fields especially cancer therapy because of their unique morphology and structure, special physicochemical properties, excellent biocompatibility, and synergistic effect. However, most reviews focused on the application of BMNs in cancer diagnoses (sensing, and imaging) and rarely mentioned the application of the treatment of cancer. The purpose of this review is to provide a comprehensive perspective on the recent progress of BNMs as therapeutic agents. We first introduce and discuss the synthesis methods, intrinsic properties (size, morphology, and structure), and optical and catalytic properties relevant to cancer therapy. Then, we highlight the application of BMNs in cancer therapy (e.g., drug/gene delivery, radiotherapy, photothermal therapy, photodynamic therapy, enzyme-mediated tumor therapy, and multifunctional synergistic therapy). Finally, we put forward insights for the forthcoming in order to make more comprehensive use of BMNs and improve the medical system of cancer treatment.

show abstract